"Mainz Biomed partners with Quest for colorectal cancer screening test" was originally created and published by Medical ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

Its research also concludes that African Americans have the highest rates of colorectal cancer when compared to any ...

The in-vitro colorectal cancer screening tests market is set for significant growth, driven by advancements in diagnostics ...

While bowel cancer – or colorectal cancer – has traditionally been more common in people over the age of 50, cases in the ...

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has ...

Bowel cancer, also known as colorectal cancer, is an aggressive cancer with a high incidence in developed countries.

In preliminary data, the test has demonstrated ‘promising’ specificity and sensitivity in detecting early-stage colorectal cancer and advanced ... the ColoAlert test kit, contingent upon ...

BERKELEY, Calif. and MAINZ, Germany, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ...